Inlexzo 57894-0225
Generic: Gemcitabine Intravesical
Product NDC
57894-0225- Manufacturer
- Janssen Biotech, Inc
- Dosage Form
- System
- Route
- Intravesical
- Product Type
- Human Prescription Drug
- Marketing Start
- September 14, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA219683
Need to source Inlexzo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gemcitabine | 225 mg/1 |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(2)
1 SYSTEM in 1 BOX (57894-225-01)
1 SYSTEM in 1 BOX (57894-225-99)